Physician profile
Aaron Thomas Lloyd
NPI 1043297856
$6,309.45
in general payments reported to CMS, 2019-2025
24 companies · $1,992 in 2025
The $1,992 reported for 2025 was more than what 78% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,297 · 2020: $150 · 2021: $176 · 2022: $644 · 2023: $883 · 2024: $1,169 · 2025: $1,992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,374 · Travel and Lodging: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,373.70 |
| Travel and Lodging | $669.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,190.39 | 2021-2025 | Synchromedii, Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Globus Medical, INC. | $1,134.27 | 2025 | Senza |
| Abbott Laboratories | $1,105.19 | 2019-2025 | Proclaim, Eterna, Ionicrf |
| Boston Scientific Corporation | $674.04 | 2019-2025 | Intracept, General - Pain Management, General - Therapies |
| Nevro Corp. | $413.87 | 2019-2024 | Senza |
| Biotronik Nro, INC. | $268.88 | 2024-2025 | Prospera |
| Curonix LLC | $237.45 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $225.91 | 2019-2022 | |
| Grt US Holding, INC. | $204.00 | 2022 | |
| Spinal Simplicity, LLC | $161.72 | 2020-2025 | Ha Minuteman G3-R |
| Medtronic USA, INC. | $145.34 | 2019-2020 | |
| Nalu Medical, INC. | $134.22 | 2024-2025 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $109.43 | 2023-2025 | Evoke Scs, Evoke |
| Teva Pharmaceuticals USA, INC. | $59.95 | 2019-2020 | |
| Vertiflex, INC. | $42.62 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $42.11 | 2023-2024 | Xtampza |
| Vertex Pharmaceuticals Incorporated | $39.96 | 2025 | |
| Vertos Medical, INC. | $33.06 | 2020 | |
| Si-Bone, INC. | $19.08 | 2019 | |
| Tonix Medicines, INC. | $16.48 | 2025 | Tonmya |
| Mdd US Operations, LLC | $14.85 | 2019 | |
| Allergan, INC. | $12.49 | 2019 | |
| Biodelivery Sciences International, INC. | $12.31 | 2019 | |
| Supernus Pharmaceuticals, INC. | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Lloyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.